Primary PCI Use Down for Cancer Patients With STEMI
WEDNESDAY, Feb. 17, 2021 -- Patients with active cancer who have ST-elevation myocardial infarction (STEMI) receive primary percutaneous coronary intervention (pPCI) less often, but they have significantly lower rates of in-hospital all-cause...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Angioplasty | Cancer | Cancer & Oncology | Coronary Angioplasty | Heart Attack | Hospitals | Percutaneous Coronary Intervention | Pharmaceuticals